'Positive' trial for Pfizer-BioNTech COVID-flu jab
The messenger RNA method made its debut with the Pfizer-BioNTech coronavirus vaccine, which was the first jab against COVID to be approved in the West in late 2020. Pfizer and BioNTech first announced in November 2022 that they were planning to use the same technology to develop a combined COVID and flu vaccine.